// App-Quantinova.ai

1539 : Low Molecular Weight Heparin Modulates Thrombin Generation in Cancer Patients Undergoing Antithrombotic Therapy for Overt Venous Thromboembolism

Researchers

Presenter

  • Anna Falanga

Principal Investigators

  • Carmen J Tartari

  • Marina R Marchetti

  • Laura Russo

  • Kim WFM Lambregts

  • Davide Resta

  • Andrea -Alessio

Medical Centers

  • Division of Onco-hematology, Policlinico San Marco, Zingonia-Bergamo, Italy

  • Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy

  • Medical School, University of Maastricht, Maastricht, Netherlands

Locations

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Catalase

  • Periplakin

  • D-dimer

Drug/Treatment

  • Evithrom

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved